Clinical study of herpes simplex virus infection in leukemia

Oral Surgery, Oral Medicine, Oral Pathology

Volumn 70, Issue 1, 1990, Pages 38-43

  Epstein, Joel B ^a,b,c,d   Sherlock, Christopher ^a,c,e   Page, Janis L ^a,b   Spinelli, John ^b   Phillips, Gordon ^c,f  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF WASHINGTON   (United States)

^e Diagnostic Virology and Reference Laboratory University of British Columbia ^*  (Canada)

^f Leukemia Bone Marrow Transplant Program of British Columbia   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HERPES SIMPLEX VIRUS; HERPES VIRUS INFECTION; HUMAN; LEUKEMIA; MALE; PRIORITY JOURNAL;

ACYCLOVIR; ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; FEMALE; HUMAN; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGE; MONOCYTES; NEUTROPHILS; SIMPLEXVIRUS; STOMATITIS, HERPETIC;

EID: 0025289607     PISSN: 00304220     EISSN: None     Source Type: Journal    
DOI: 10.1016/0030-4220(90)90175-R     Document Type: Article

References (37)

1. Recurrent infection with herpes simplex virus after marrow transplantation: role of the specific immune response and acyclovir treatment
2. Chronic oral herpes simplex virus infection in immunocompromised patients
3. Herpes simplex infections in hematologic malignancies
4. Chronic cutaneous herpes simplex
5. Herpes simplex virus infection: biology, treatment, prevention
6. Reactivation of herpes simplex virus (type 2) infection in trigeminal ganglia and oral lips with cyclophosphamide treatment
7. Infection with herpes simplex viruses 1 and 2 (second of three parts)
8. The role of immunity in latency and reactivation of herpes simplex viruses
9. The role of an immunoperoxidase technique in the diagnosis of oral herpes simplex virus infection in patients with leukemia
10. A comparative study of herpes simplex infections in renal transplant and leukemic patients
11. A long term prospective clinical study of orofacial herpes simplex virus infection in acute leukemia
12. The incidence of oral herpes simplex virus infection in patients undergoing cancer chemotherapy
13. Acyclovir prophylaxis for oral HSV in bone marrow transplant patients
14. Oropharyngeal herpes simplex virus (HSV) infections following bone marrow transplantations
15. Neurologic symptoms associated with parenteral acyclovir treatment after marrow transplantation
16. Acyclovir therapeutic efficacy
17. Prophylaxis: a strategy to minimise antiviral resistance
18. Update on antiviral chemotherapy: the advent of acyclovir
19. Resistance to anti-viral drugs of herpes simplex cirus isolated from a patient treated with acyclovir
20. Isolation and characterization of resistant herpes simplex virus after acyclovir therapy
21. Acyclovir for chronic mucocutaneous herpes simplex virus infection in immunosuppressed patients
22. Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir
23. Chronic herpetic infection in an immunocompromised patient: report of a case
24. Herpes virus hominis infection in patients with myeloproliferative and lymphoproliferative disorders
25. Effect of acyclovir treatment of primary genital herpes on the antibody response to herpes simplex virus
26. Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation
27. Herpes simplex infection in acute myelogenous leukemia and other hematologic malignancies: a prospective study
28. Cancer chemotherapy associated symptomatic stomatitis: role of herpes simplex virus (HSV)
29. Oral acyclovir to suppress recurring herpes simplex virus infections in immunodeficient patients
30. Viral infections in immunosuppressed patients
31. Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation
32. Lymphocyte blastogenesis and interferon production in adult human leukocyte cultures stimulated with cytomegalovirus antigens
33. Impaired monocyte-macrophage cytotoxicity in patients with Hodgkin's disease
34. Correlation between low natural killing of fibroblasts infected with herpes simplex virus type 1 and susceptibility to herpesvirus infections
35. Natural killing of herpes simplex virus type 1-infected target cells: normal human responses and influence of antiviral antibody
36. Cellular immunity to herpes simplex virus in man. VII. K-cell activity to HSV-1 infected target cells in disease
37. Cellular immune response in genital herpes simplex virus infection